期刊文献+

VEGF,β-连环素及uPA在子宫内膜癌中的表达及意义 被引量:4

Expression and significance of VEGF, β-catenin and uPA in endometrial carcinoma
下载PDF
导出
摘要 目的:探讨血管内皮生长因子(VEGF)、β-连环素(β-catenin)和尿激酶型纤溶酶原激活剂(uPA)在子宫内膜癌组织中的表达和临床意义。方法:用免疫组化SP法检测VEGF,β-catenin和uPA在49例子宫内膜癌和13例正常子宫内膜组织中的表达。结果:VEGF,β-catenin和uPA在子宫内膜癌中的阳性率分别为69.4%,61.2%和77.6%。VEGF的表达在子宫内膜癌不同的子宫肌层的浸润深度之间差异有统计学意义(P=0.004),β-catenin的表达在子宫内膜癌不同组织病理分级和子宫肌层浸润深度之间差异有统计学意义(P=0.036,P=0.016);uPA表达在不同组织病理分级和子宫肌层浸润深度间差异有统计学意义(P=0.044,P=0.038)。三者在子宫内膜癌中的表达具有相关性。结论:VEGF,β-catenin及uPA与子宫内膜癌的发展侵袭相关。三者的异常表达共同作用促进子宫内膜癌的发展和侵袭。 Objective: This study was designed to analyze the expression and clinical significance of VEGF, β-catenin and uPA in endometrial cancer tissue samples. Methods: We selected tissues from 49 cases of of endometrial cancer and from 13 normal endometrial samples, and evaluated the expression of VEGF, β-catenin and uPA by immunohistochemistry. Results: Positive staining for VEGF was present in 69.4% of endometrial cancer tissues samples, while 61.2% of the samples were positive for β-catenin, and 77.6% stained positively for uPA. There was a statistically significant difference in the level of myometrial infiltration that correlated with the expression of VEGF in endometrial cancer tissue samples (P =0.004). The expression of β-catenin also correlated with the histological grade and myometrial infiltration (P =0.036, P =0.016), while uPA was statistically significant difference in the different histological grade and myometrial infiltration (P =0.044,P =0.038). Conclusions: The expression of VEGF, β-catenin and uPA in tumor tissue has a significant correlation with the level of invasion of endometrial cancer. The expression of VEGF, β-catenin and uPA apparently plays an essential role in the development and invasion of carcinoma of the endometrium.
出处 《国际妇产科学杂志》 CAS 2008年第4期297-299,共3页 Journal of International Obstetrics and Gynecology
关键词 子宫内膜癌 血管内皮生长因子 Β-连环素 尿激酶型纤溶酶原激活物 免疫组织化学 发展 侵袭 Endometrialcarcinoma VEGF β-catenin uPA Immunohistochemistry Development Invasion
  • 相关文献

参考文献3

二级参考文献15

  • 1蒋红元,丰有吉.卵巢上皮性癌组织中缺氧诱导因子1α的表达及其与血管内皮生长因子的相关性[J].中华妇产科杂志,2004,39(11):767-770. 被引量:11
  • 2赵仲生,茹国庆,马杰.IGF-Ⅱ和HGF mRNA表达与胃癌微血管密度的关系[J].中华肿瘤杂志,2004,26(11):673-677. 被引量:27
  • 3李节,邱平.尿激酶与肿瘤转移[J].国外医学(分子生物学分册),1994,16(1):26-29. 被引量:6
  • 4Andreasen PA, Kjoller L, Chritensen L, et al. The urokinase-type plasminogen activator system in cancer metastasis:a review[J]. Int J Cancer,1997 ,72 : 1-22
  • 5Schmalfeldt B, Prechtel D, Harting K, et al. Increased expression of matrix metalloproteinases ( MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer [J]. Clin Cancer Res,2001,7 :2396-2404
  • 6Foca C, Moses EK, Quinn MA, et al. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas [ J ]. Gynecol Oncol,2000,79:244-250
  • 7Foekens JA, Peters HA, Look MP, et al. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients[ J]. Cancer Res ,2000,60:636-643
  • 8Sakakibara T, Hibi K, Fujiwara M, et al. sPlasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer[J]. Cancer Sci ,2006,97:395-399
  • 9Pappot H, Pedersen AN, Brunner N, et al. The complex between urokinase (uPA) and its type-1 inhibitor (PAI- 1) in pulmonary adenocarcinoma: relation to prognosis [ J]. Lung Cancer,2006,51 : 193-200
  • 10Yasuda S, Arii S, Mori A et al. Hexokinase Ⅱ and VEGF expression in liver tumors : corredlation with hypoxia - inducible factor - 1 alpha and its significance. J Hepatol, 2004, 40 (1) : 117-123

共引文献21

同被引文献54

  • 1王宏,黎卫平,高云荷.子宫内膜癌中β-连环素表达及与预后的关系[J].临床与实验病理学杂志,2003,19(2):156-159. 被引量:7
  • 2刘菲,蒲力力.肥胖对女性生殖健康影响的研究进展[J].中国优生与遗传杂志,2006,14(10):1-2. 被引量:5
  • 3Hicklin DJ,Ellis LM.Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.J Clin Oncol,2005,23(5):1011-1027.
  • 4Li HW,Leung SW,Chan CS,et al.Expression of maspin in endometrioid adenocarcinoma of endometrium Oncol Rep,2007,17(2):393-398.
  • 5Tammela T,Enholm B,Alitalo K,et al.The biology of vascular endothelial growth factors.Cardiovasc Res,2005,65(3):550-563.
  • 6Solomon LA,Munkarah AR,Schimp VL,et al.Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.Gynecol Oncol,2006,101 (3):385-389.
  • 7Parenti A,Leo G,Porzionato A,et al.Expression of sur-vivin,p53,and caspase 3 in Barrett's esophagus carcino-genesis[J].Hum Pathol,2006,37:16-22.
  • 8De Clerck YA,Mercurio AM,Stack MS,et al.Proteases,extracellular matrix and cancer:aworkshop of the path Bstudy section[J].Am J Pathol,2004,164(4):1131-1139.
  • 9Hildenbrand R,Gandhari M,Stroebel P,et al.The urokinasesyste mrole of cell proliferation and apoptosis[J].HistolHistopathol,2008,23(2):227-236.
  • 10Hofmann HS,Bartling B,Simm A,et al.Identificationand classification of differentiallyexpressed genes in non-small cell lung cancer by expression profiling on a globalhuman 59.620-element oligonucleotide array[J].OncolRep,2006,16(3):587-595.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部